Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia

J Rehabil Med. 2019 Jun 18;51(6):434-441. doi: 10.2340/16501977-2556.

Abstract

Objective: To investigate the functional effects of bilateral botulinum toxin A treatment and subsequent stretching of spastic hip adductors on gait and reactive lateral stepping responses in patients with pure hereditary spastic paraplegia.

Design: Explorative pre-post intervention study.

Patients: Twenty-five patients with pure hereditary spastic paraplegia.

Methods: Patients were treated with bilateral botulinum toxin A injections in the hip adductors and performed daily self-administered stretching exercises for 16 weeks. Before the intervention (T0), and 6 (T1) and 16 (T2) weeks thereafter, gait width, gait speed, and leg angles at first stepping-foot contact after lateral balance perturbations were assessed, as well as the corresponding success rates of reactive lateral steps.

Results: Compared with baseline, gait width increased by 12.6% and 9.7% and comfortable gait speed by 8.3% and 11.5% at T1 and T2, respectively. In known perturbation directions, leg angles increased by 5.9% at T1 and 8.0% at T2, while success rates increased from 70% at baseline to 90% at T1 and T2. No effects were found for maximal gait speed or lateral stepping responses in unknown perturbation directions.

Conclusion: Bilateral botulinum toxin A treatment and subsequent stretching of the hip adductors may improve gait and reactive lateral stepping in patients with pure hereditary spastic paraplegia.

Keywords: balance control; botulinum toxin; gait; hereditary spastic paraplegia.

MeSH terms

  • Adult
  • Aged
  • Botulinum Toxins, Type A / administration & dosage*
  • Combined Modality Therapy
  • Female
  • Gait / physiology
  • Hip / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Muscle Stretching Exercises / methods*
  • Neuromuscular Agents / administration & dosage*
  • Spastic Paraplegia, Hereditary / physiopathology
  • Spastic Paraplegia, Hereditary / therapy*
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A